EU Vaccine News: Sloppy vaccine rollout means quarter doesn’t want crucial hits | World

EU Vaccine News: Sloppy vaccine rollout means quarter doesn’t want crucial hits | World

The survey released Thursday showed that more than a quarter of adults in the European Union would be unlikely to take the COVID-19 vaccine if offered to them.

The results also suggest a strong link between vaccine hesitancy and social media use, especially when social media is the main source of information, according to Eurofound who conducted the survey.
Daphne Ahrendt, Senior Research Director of Eurofound, said: “Unfortunately, these results reflect a failure to provide convincing and clear communication regarding the efficacy and safety of vaccines. “

Bulgarians were the most reluctant to get the vaccine, with 67% of adults saying it was unlikely or very unlikely to get it.

In Ireland, only 10% of adults said they would not get the vaccine.

The investigation revealed an east-west divide across Europe.
With the exception of France and Austria, the intention to get vaccinated was above 60 percent in all western member states – with the Nordic and Mediterranean countries, Denmark and Ireland having even higher rates. high.

The expected turnout in the Eastern Member States was much lower, ranging from 59 percent in Romania to 33 percent in Bulgaria.

The main influence on vaccine reluctance was time spent on social media and the medium used, according to the survey.

READ MORE: Ursula von der Leyen’s vaccine crisis to the problems of the EU’s ‘experience’

Sources close to President Emmanuel Macron have warned that the government expected difficulty convincing the “bottom 10 percent” to receive the vaccine.

The counselor said, “When the last reluctant sees their friends meet up in restaurants and show up again thanks to the vaccination certificate, they will go for the vaccination.”

The Oxford jab was snubbed by several EU countries in March, including France, and its use was suspended after reports of blood clots as one of the side effects of the jab.

Just weeks after its takeover, the coup was suspended in Germany for anyone under the age of 60.

The European Medicines Agency and the World Health Organization said the benefits outweighed the very rare risks.

AstraZeneca said in March that its vaccine was 76% effective in preventing symptomatic infections in a US trial, and that studies did not indicate higher risks of clotting.

The EU has accused the drugmaker of overselling its vaccine and unfairly favoring Britain – a charge the company denied.

The investigation was conducted between February and March 2021, after a full year of living with COVID-19 restrictions in the bloc’s 27 member states.

62,518 people were contacted, of which 46,800 responded to the survey.


Please enter your comment!
Please enter your name here